Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 9 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. US 8409548

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  2. US 8338457

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    The United States of America as represented by the Secretary of the Department of Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  3. US 8334259

    Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative

    The Board of Regents of the University of Texas System · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  4. US 8293275

    Spray freeze dry of compositions for pulmonary administration

    The Regents of the University of Colorado · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  5. US 8242093

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  6. US 8182842

    Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted May 22, 2012 · Expires May 17, 2032

    granted

  7. US 8133861

    Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

    Alseres Pharmaceuticals, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted

  8. US 8119590

    Prevention and treatment of restenosis by local administration of drug

    Esperion Therapeutics, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  9. US 8093236

    Weekly administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  10. US 8092803

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  11. US 8075920

    Administration of cells and cellular extracts for rejuvenation

    REGENICS AS · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  12. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  13. US 8071074

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  14. US 8048844

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  15. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  16. US 7972821

    Production of functional proteins: balance of shear stress and gravity

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  17. US 7968117

    Externally triggered microcapsules

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  18. US 7922999

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  19. WO 2011033094

    CALENDRIER DE L'ADMINISTRATION DE DÉRIVÉS DE BENZAZOLE DANS LE TRAITEMENT DE LEUCÉMIES

    4SC AG [DE] · Granted Mar 24, 2011 · Expires Mar 19, 2031

    granted

  20. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  21. WO 2010146171

    NOUVELLE MÉTHODE D'ADMINISTRATION D'UN ALLERGÈNE DANS UNE IMMUNOTHÉRAPIE ALLERGÈNE-SPÉCIFIQUE

    ALK ABELLO AS [DK] · Granted Dec 23, 2010 · Expires Dec 18, 2030

    granted

  22. US 7855176

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  23. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  24. US 7807645

    Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.